HMGB1 and COVID-19: In severe COVID-19 patients, multiple DAMPs, including HMGB1 and S100 proteins, are significantly increased due to the massive release of inflammatory mediators and the occurrence of cell death, thereby causing the body's immune response disorders and aggravating the progression of COVID-1921.